Mediastinoscopy vs endosonography for mediastinal nodal staging of lung cancer
ASTER trial design and results
Design
Randomised controlled trial
Treatment
Endosonography (endobronchial and endoscopic ultrasound) followed by surgical staging if negative
Control
Surgical staging alone
Population
241 patients with known or suspected non-small-cell lung cancer
Follow-up
6 months
Primary endpoint
Sensitivity for mediastinal nodal metastases
Result
Sensitivity was 79% (41 of 52, 95% CI 66% to 88%) for surgical staging alone versus 85% (56 of 66, 74% to 92%) for endosonography (p=0.47) and 94% (62 of 66, 85% to 98%) for the combined strategy (p=0.02). Unnecessary thoracotomy occurred in 21 (18%) with mediastinoscopy versus 9 (7%) with endosonography (p=0.02). Complication rates were similar.
Secondary endpoints
Unnecessary thoracotomy, complications
Among patients with (suspected) NSCLC, a staging strategy combining endosonography and surgical staging compared with surgical staging alone resulted in greater sensitivity for mediastinal nodal metastases and fewer unnecessary thoracotomies.
The trial authors, in the published abstract
How it has aged
Made EBUS the first-line mediastinal staging investigation and pushed mediastinoscopy into a confirmatory role. The important number is the 18% to 7% fall in unnecessary thoracotomy — a major operation avoided in one patient in nine.
Publications
Mediastinoscopy vs endosonography for mediastinal nodal staging of lung cancer: a randomized trial
Annema JT, van Meerbeeck JP, Rintoul RC, et al. Mediastinoscopy vs endosonography for mediastinal nodal staging of lung cancer: a randomized trial. JAMA 2010 Nov 24;304(20):2245-52.
Sensitivity 94% for the combined strategy versus 79% for surgical staging alone